- Home
- AFBI vs UNCY Comparison
AFBI vs UNCY Comparison
Compare AFBI & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AFBI | UNCY |
|---|---|---|
| Founded | 1928 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.3M | 145.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AFBI | UNCY |
|---|---|---|
| Price | $18.90 | $6.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $44.50 |
| AVG Volume (30 Days) | 2.4K | ★ 431.9K |
| Earning Date | 05-08-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.25 |
| EPS | ★ 0.96 | N/A |
| Revenue | N/A | ★ $675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.53 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.05 | $0.45 |
| 52 Week High | $22.25 | $7.57 |
Technical Indicators
Market Signals| Indicator | AFBI | UNCY |
|---|---|---|
| Relative Strength Index (RSI) | 35.52 | 47.85 |
| Support Level | $18.60 | $6.48 |
| Resistance Level | $18.87 | $6.82 |
| Average True Range (ATR) | 0.29 | 0.31 |
| MACD | -0.09 | -0.04 |
| Stochastic Oscillator | 15.23 | 23.49 |
Price Performance
Historical ComparisonAbout AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.